UK Markets closed

Invitae Corporation (NVTA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
30.83-0.71 (-2.25%)
At close: 04:00PM EDT
30.60 -0.23 (-0.75%)
After hours: 05:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close31.54
Bid30.72 x 1300
Ask31.20 x 900
Day's range29.90 - 31.10
52-week range24.16 - 61.59
Avg. volume3,209,625
Market cap6.16B
Beta (5Y monthly)1.90
PE ratio (TTM)N/A
EPS (TTM)-3.88
Earnings date04 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est40.44
  • Motley Fool

    Cathie Wood Goes Bargain Shopping: 3 Sinking Stocks She Keeps Buying

    If you're Cathie Wood, founder, and CEO of ARK Invest, you keep buying more. Shares of life-science equipment manufacturer Berkeley Lights (NASDAQ: BLI) took a hit last week, and two ARK Invest ETFs quickly bought more. Wood also bought two genomics stocks that have tanked this year, Personalis (NASDAQ: PSNL) and Invitae (NYSE: NVTA).

  • Motley Fool

    Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought

    All of these stocks are more than 40% below their peaks, but at least one important investor thinks they can recover.

  • Motley Fool

    Why Did Invitae Stock Fall 17% in July?

    Invitae (NYSE: NVTA) shares dropped 17% in July as investors moved capital away from the smaller innovative genomic science stocks. No meaningful news was published about the stock, though there were announcements that other care providers would be partnering with Invitae to add genetic testing to their service selection. Invitae is a relatively small and unprofitable company with massive growth aspirations.